Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Since Caterpillar - Feb 3, 2010

Very well said. Logically thought out. I'll use 40 million as the benchmark. Below that figure and the BOD disappoints again. Above that figure and there would be a nice pop in the SP. I think next week holds several bits of news we've waited for and I have high expectations of nice news for shareholders.

Long & Strong

Share
New Message
Please login to post a reply